Device Icefx_pi

Icefx Cryoablation System

Payments companies reported to CMS as associated with Icefx Cryoablation System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$83Kassociated payments (2023-2025)
497clinicians with associated payments
1company reporting

By year

2023 $14K
2024 $11K
2025 $58K

Payments reported as associated with Icefx Cryoablation System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Vascular & Interventional Radiology $31K
Diagnostic Radiology $28K
Clinical Cardiac Electrophysiology $6,043
Cardiovascular Disease $3,310
Interventional Cardiology $2,654
Physician Assistant $2,546

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Icefx Cryoablation System

These are the largest totals companies reported as associated with Icefx Cryoablation System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mike Sheng Philadelphia, PA Vascular & Interventional Radiology $2,182.90
Avneesh Chhabra Dallas, TX Diagnostic Radiology $1,838.42
Anthony Tadros San Diego, CA Vascular & Interventional Radiology $1,678.71
Yuanlong Zhao Las Vegas, NV Vascular & Interventional Radiology $1,654.08
Edwin Stanley Waussau, WI Diagnostic Radiology $1,645.58
Matthew Grove Gainesville, FL Vascular & Interventional Radiology $1,629.42
Saquib Khawar Springfield, IL Diagnostic Radiology $1,525.46
Scott Genshaft Los Angeles, CA Diagnostic Radiology $1,439.22
Christopher Granville Forest City, PA Diagnostic Radiology $1,433.75
Hugh Davis Gainesville, FL Diagnostic Radiology $1,421.92

Prescribed Icefx Cryoablation System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.